Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sultiame 200mg tablets
0408010Y0AAABAB
|
Sultiame | Sultiame | Central Nervous System | 42 |
|
Sultiame 50mg tablets
0408010Y0AAAAAA
|
Sultiame | Sultiame | Central Nervous System | 27 |
|
Ospolot 50mg tablets
0408010Y0BBAAAA
|
Ospolot | Sultiame | Central Nervous System | 1 |
|
Ospolot 200mg tablets
0408010Y0BBABAB
|
Ospolot | Sultiame | Central Nervous System | No data available |
|
Ospolot 20mg/ml oral suspension
0408010Y0BBACAE
|
Ospolot | Sultiame | Central Nervous System | No data available |
|
Sultiame 100mg tablets
0408010Y0AAADAD
|
Sultiame | Sultiame | Central Nervous System | No data available |
|
Sultiame 20mg/ml oral suspension
0408010Y0AAAEAE
|
Sultiame | Sultiame | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.